Xinfang Yu

2.9k total citations
53 papers, 2.0k citations indexed

About

Xinfang Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xinfang Yu has authored 53 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 24 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Xinfang Yu's work include Cancer-related Molecular Pathways (14 papers), Ubiquitin and proteasome pathways (12 papers) and Cell death mechanisms and regulation (8 papers). Xinfang Yu is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Ubiquitin and proteasome pathways (12 papers) and Cell death mechanisms and regulation (8 papers). Xinfang Yu collaborates with scholars based in China, United States and Saudi Arabia. Xinfang Yu's co-authors include Haidan Liu, Ya Cao, Li Zhou, Huijun Wu, Xuewen Gao, Ann M. Bode, Wenbin Liu, Feng Gao, Rainer Borriss and Liming Wu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Xinfang Yu

47 papers receiving 2.0k citations

Peers

Countries citing papers authored by Xinfang Yu

Since Specialization

Citations

This map shows the geographic impact of Xinfang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinfang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinfang Yu more than expected).

Fields of papers citing papers by Xinfang Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinfang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinfang Yu. The network helps show where Xinfang Yu may publish in the future.

Co-authorship network of co-authors of Xinfang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinfang Yu. A scholar is included among the top collaborators of Xinfang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinfang Yu. Xinfang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	E3 ligase Skp2-mediated stabilization of survivin contributes to radioresistance 2025 ·Cell Death Discovery ·Shiming Tan, Ruirui Wang, (unknown), Ming Yi, Pengfei Guo, Shuangze Han, (unknown), (unknown), (unknown), Xinfang Yu, Wei Li	0
2	Lipid nanoparticles deliver DNA-encoded biologics and induce potent protective immunity 2025 ·Molecular Cancer ·Dafei Chai, Junhao Wang, (unknown), Xiaohui Xie, Xinfang Yu, Dan Zhao, (unknown), (unknown), (unknown), Ken H. Young, Yong Li	2
3	Integrated Transcriptomic, Proteomic, and Metabolomic Analyses Reveal Mechanisms Underlying Day–Night Differences in Carbohydrate Metabolism between Diploid and Tetraploid Rice 2025 ·Rice ·(unknown), Yuchen Liu, Changjiang Zhang, Xiaohong Zhan, (unknown), Xinfang Yu, Chunying Zhang, (unknown), Jian Ma	0
4	Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation 2024 ·Blood ·Wei Li, (unknown), Junhao Wang, Dafei Chai, Xiao‐Song Xie, Ken H. Young, Ya Cao, Yong Li, Xinfang Yu	2
5	Transcriptome-Wide Analysis of Core Transcription Factors Associated with Defense Responses in Autotetraploid versus Diploid Rice under Saline Stress and Recovery 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Xinfang Yu, (unknown), Yuchen Liu, Minghong Xu, (unknown), Fan Qi, (unknown), Yan Xu, Jian Ma, Chunying Zhang	1
6	Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells 2023 ·Communications Biology ·Huiling Zhou, Li Zhou, (unknown), Xuyang Hou, Cong Wang, Lijun Liu, Jian Wang, Xinfang Yu, Wei Li, Haidan Liu	20
7	Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance 2022 ·Cell Death and Disease ·Ming Li, Feng Gao, (unknown), Yu Gan, Shuangze Han, Xinfang Yu, Haidan Liu, Wei Li	14
8	Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study 2021 ·Signal Transduction and Targeted Therapy ·Ya Cao, Longlong Xie, Feng Shi, Min Tang, Yueshuo Li, Jianmin Hu, Lin Zhao, Luqing Zhao, Xinfang Yu, Xiangjian Luo, Weihua Liao, Ann M. Bode	74
9	MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis 2020 ·Blood ·Xinfang Yu, Wei Li, Qipan Deng, Haidan Liu, Xu Wang, Hui Hu, Ya Cao, Zijun Y. Xu‐Monette, Ling Li, Mingzhi Zhang, Zhongxin Lu, Ken H. Young, Yong Li	26
10	<p>Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis</p> 2020 ·OncoTargets and Therapy ·Wenbin Liu, Xinfang Yu, Li Zhou, Jigang Li, Ming Li, Wei Li, Feng Gao	22
11	Targeting PD-L1 in non-small cell lung cancer using CAR T cells 2020 ·Oncogenesis ·(unknown), Xu Wang, Wei Li, Xinfang Yu, Pedro O. Flores-Villanueva, Zijun Y. Xu‐Monette, Ling Li, Mingzhi Zhang, Ken H. Young, Xiaodong Ma, Yong Li	67
12	Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant 2019 ·Nature Communications ·Qipan Deng, Hui Hu, Xinfang Yu, Shuanglin Liu, Lei Wang, Weiqun Chen, Chi Zhang, Zhaoyang Zeng, Ya Cao, Zijun Y. Xu‐Monette, Ling Li, Mingzhi Zhang, Steven Rosenfeld, Shideng Bao, Eric D. Hsi, Ken H. Young, Zhongxin Lu, Yong Li	19
13	Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis 2019 ·International Journal of Biological Sciences ·Wenbin Liu, Wei Li, Haidan Liu, Xinfang Yu	67
14	MYD88 L265P Mutation in Lymphoid Malignancies 2018 ·Cancer Research ·Xinfang Yu, Wei Li, Qipan Deng, Ling Li, Eric D. Hsi, Ken H. Young, Mingzhi Zhang, Yong Li	81
15	Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1/3 ubiquitination 2018 ·Cell Death and Disease ·Xiaolan Liu, Yueshuo Li, (unknown), Xinfang Yu, Wei Li, Feng Shi, Xiangjian Luo, Min Tang, Zheqiong Tan, Ann M. Bode, Ya Cao	62
16	Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis 2017 ·BMC Cancer ·Xinfang Yu, Wei Li, Zhenkun Xia, Li Xie, Xiaolong Ma, Qi Liang, Lijun Liu, Jian Wang, Xinmin Zhou, Yifeng Yang, Haidan Liu	41
17	Difficidin and bacilysin from Bacillus amyloliquefaciens FZB42 have antibacterial activity against Xanthomonas oryzae rice pathogens 2015 ·Scientific Reports ·Liming Wu, Huijun Wu, Lina Chen, Xinfang Yu, Rainer Borriss, Xuewen Gao	228
18	The role of targeting kinase activity by natural products in cancer chemoprevention and chemotherapy (Review) 2015 ·Oncology Reports ·Xiangjian Luo, Xinfang Yu, Sufang Liu, Qipan Deng, Xiaolan Liu, (unknown), Hongde Li, Ji‐Kai Liu, Ya Cao	35
19	Neoalbaconol induces energy depletion and multiple cell death in cancer cells by targeting PDK1-PI3-K/Akt signaling pathway 2013 ·Cell Death and Disease ·Qipan Deng, Xinfang Yu, Lanbo Xiao, Zhilan Hu, Xiangjian Luo, Yongguang Tao, Lifang Yang, Xiaowen Liu, (unknown), (unknown), Tao Feng, Yuchen Tang, Xisheng Weng, (unknown), Wenjun Yi, Ann M. Bode, Zigang Dong, Jiangying Liu, Ya Cao	66
20	The role of necroptosis, an alternative form of cell death, in cancer therapy 2013 ·Expert Review of Anticancer Therapy ·Xinfang Yu, Qipan Deng, Ann M. Bode, Zigang Dong, Ya Cao	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact